河南省城市地区乳腺癌筛查依从性及其影响因素分析

doi:10.11904/j.issn.1002-3070.2021.04.004

实用肿瘤学杂志 ›› 2021, Vol. 35 ›› Issue (4): 307-313.doi: 10.11904/j.issn.1002-3070.2021.04.004

河南省城市地区乳腺癌筛查依从性及其影响因素分析

郭兰伟, 张韶凯, 刘曙正, 郑黎阳, 陈琼, 曹小琴, 孙喜斌, 张建功

河南省肿瘤防治研究办公室,河南省肿瘤防控工程研究中心,河南省肿瘤预防国际联合实验室,郑州大学附属肿瘤医院/河南省肿瘤医院(郑州 450008)

收稿日期:2021-03-09 修回日期:2021-06-04 发布日期:2021-08-24
通讯作者: 张建功,E-mail:jgzhang01@126.com
作者简介:郭兰伟,男,(1987-),博士,主治医师,从事癌症筛查相关的研究。

Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province

GUO Lanwei, ZHANG Shaokai, LIU Shuzheng, ZHENG Liyang, CHEN Qiong, CAO Xiaoqin, SUN Xibin, ZHANG Jiangong

Henan Office for Cancer Control and Research,Henan Engineering Research Center of Cancer Prevention and Control,Henan International Joint Laboratory of Cancer Prevention,The Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Zhengzhou 450008,China

Received:2021-03-09 Revised:2021-06-04 Published:2021-08-24

摘要/Abstract

摘要： 目的评价2013—2019年河南省城市地区乳腺癌高危人群筛查依从性并探索可能的影响因素。方法选取河南省40~74岁城市户籍居民进行癌症危险因素调查和乳腺癌风险评估。对于乳腺癌高危人群,40~44岁者行乳腺超声检查;45岁以上者,行乳腺超声联合X线摄影(钼靶)检查。比较不同特征人群的乳腺癌筛查参与率并分析乳腺癌筛查参与率的影响因素。结果本研究共纳入符合研究要求的乳腺癌高危人群29 111例,其中13 760例接受了乳腺癌筛查,总体参与率为47.27%。乳腺癌筛查的参与率存在着显著的地区和时间差异:最高和最低城市的参与率分别为74.24%和 40.00%;2013—2014年度的总体筛查参与率最低为40.66%,2017—2018年度的总体筛查参与率最高为51.05%。多因素Logistic回归分析提示,45~64岁、具有初中及以上学历、正在吸烟或既往吸烟、正在饮酒或既往饮酒、体育锻炼缺乏、初潮年龄＜12岁、已绝经、有生育史、有乳腺良性疾病史、有乳腺癌家族史和有卵巢癌家族史的人群更愿意接受乳腺癌筛查。结论我省城市乳腺癌高危人群的乳腺癌筛查参与率不足48%,未来需针对特定人群采取措施提升乳腺癌筛查的总体依从性。

关键词: 乳腺癌, X线摄影, 超声, 筛查, 依从性

Abstract: Objective The objective of this study was to evaluate the compliance of breast cancer screening among high-risk population in urban areas of Henan province from 2013 to 2019 and explore possible influencing factors. Methods The urban residents aged 40~74 years old in Henan province were selected for cancer risk factor survey and breast cancer risk assessment.For people at high risk of breast cancer,breast ultrasound examination was performed for those aged 40~45 years old,and breast ultrasound combined with X-ray photography(molybdenum target)examination for those over 45 years old.The participation rate of breast cancer screening among people with different characteristics was compared and further analyzed its influencing factors. Results A total of 29,111 cases of breast cancer high-risk population that met the research requirements were included in the study,of which 13,760 cases were screened for breast cancer,and the overall participation rate was 47.27%.There were significant regional and time differences in the participation rate of breast cancer screening:the participation rates in the highest and lowest cities were 74.24% and 40.00%,respectively;the overall screening participation rate from 2013 to 2014 was the lowest 40.66% and the highest 51.05% from 2017 to 2018.The multivariate logistic regression analyses suggested:45~64 years old,with junior high school degree or above,smoking or smoking in the past,drinking or drinking in the past,lack of physical exercise,menarche age ＜12 years,menopause,history of fertility,history of benign breast disease,a family history of breast cancer,and a family history of ovarian cancer were more willing to accept breast cancer screening. Conclusion The overall participation rate of breast cancer screening among high-risk population of urban breast cancer in Henan province is less than 48%.The measures should be taken for specific populations to improve the overall compliance of breast cancer screening in the future.

Key words: Breast cancer, Mammography, Ultrasound, Screening, Compliance

中图分类号:

R181.2+3

郭兰伟, 张韶凯, 刘曙正, 郑黎阳, 陈琼, 曹小琴, 孙喜斌, 张建功. 河南省城市地区乳腺癌筛查依从性及其影响因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 307-313.

GUO Lanwei, ZHANG Shaokai, LIU Shuzheng, ZHENG Liyang, CHEN Qiong, CAO Xiaoqin, SUN Xibin, ZHANG Jiangong. Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province[J]. Journal of Practical Oncology, 2021, 35(4): 307-313.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2021.04.004

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2021/V35/I4/307

参考文献

1 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
2 Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14(concord-3):Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J].Lancet(London,England),2018,391(10125):1023-1075.
3 陈万青,郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床,2015,42(13):668-674.
4 李霓,郑荣寿,张思维,等.中国城乡女性乳腺癌发病趋势分析和预测[J].中华预防医学杂志,2012,46(8):703-707.
5 Oeffinger KC,Fontham ET,Etzioni R,et al.Breast cancer screening for women at average risk:2015 guideline update from the american cancer society[J].JAMA,2015,314(15):1599-1614.
6 Fan L,Strasser-Weippl K,Li JJ,et al.Breast cancer in china[J].Lancet Oncol,2014,15(7):279-289.
7 Stomper PC,D′Souza DJ,DiNitto PA,et al.Analysis of parenchymal density on mammograms in 1353 women 25-79 years old[J].AJR Am J Roentgenol,1996,167(5):1261-1265.
8 Zulfiqar M,Rohazly I,Rahmah M.Do the majority of malaysian women have dense breasts on mammogram?[J].Biomed Imaging Interv J,2011,7(2):e14.
9 Senore C,Inadomi J,Segnan N,et al.Optimising colorectal cancer screening acceptance:A review[J].Gut,2015,64(7):1158-1177.
10 Bulliard JL,Garcia M,Blom J,et al.Sorting out measures and definitions of screening participation to improve comparability:The example of colorectal cancer[J].Eur J Cancer,2014,50(2):434-446.
11 代敏,石菊芳,李霓.中国城市癌症早诊早治项目设计及预期目标[J].中华预防医学杂志,2013,47(2):179-182.
12 周星彤,沈松杰,孙强.中国乳腺癌筛查现状及进展[J].中国医学前沿杂志(电子版),2020,12(3):6-11.
13 左婷婷,吴颖,董首兰,等.辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析[J].实用肿瘤学杂志,2020,34(5):387-390.
14 张强,黄云超,沈丽达,等.云南省127960名城市居民癌症风险评估及筛查结果分析[J].中国肿瘤,2018,27(9):641-646.
15 汪雯,李辉章,朱陈,等.浙江省2014-2015年度居民癌症风险评估及筛查结果分析[J].浙江医学,2016,38(22):1795-1798.
16 刘亚洲,孔蕴馨,罗小虎,等.2014-2016年徐州市城市癌症早诊早治筛查分析[J].江苏预防医学,2018,29(4):382-385.
17 肖海帆,颜仕鹏,许可葵,等.湖南省2012-2018年城市癌症早诊早治项目临床筛查结果初步分析[J].中国肿瘤,2019,28(11):807-815.
18 廖先珍,颜仕鹏,石菊芳,等.城市女性乳腺癌高危评估及筛查结果分析[J].实用肿瘤学杂志,2016,30(3):245-248.
19 齐亚莉,张文英,张国宝,等.女性乳腺癌危险因素Meta分析[J].中国肿瘤,2007,16(1):14-15.
20 张建斌,冯向先.乳腺癌危险因素的Meta分析[J].中国卫生统计,2002,19(3):168-170.
21 董佩,邱五七,石菊芳,等.我国城市居民癌症筛查服务利用现况及服务支付意愿分析[J].中华流行病学杂志,2018,39(2):165-172.

[1]	秦朝, 李江, 郑亚迪, 王飞, 曹巍, 许永杰, 余一雯, 赵亮, 于欣阳, 陈宏达, 任建松, 王勇, 李静, 李霓, 陈万青. 中国城市乳腺癌高危人群筛查依从性及其相关因素分析[J]. 实用肿瘤学杂志, 2021, 35(4): 291-296.
[2]	庹吉妤, 张霞, 何晓梅, 姜文珍, 冯觉平, 金霞, 张敏, 魏少忠. 湖北省2018-2019年城市癌症早诊早治项目筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(4): 297-301.
[3]	魏东华, 马艳玲, 张娟, 尹惠萍, 张小鹏, 张愉涵, 代敏, 钱立庭. 2014-2016年合肥市城市居民肺癌筛查率及筛查结果分析[J]. 实用肿瘤学杂志, 2021, 35(3): 231-236.
[4]	黎敏, 冉立, 常建英. 影像学技术在图像引导宫颈癌近距离放射治疗中的应用[J]. 实用肿瘤学杂志, 2021, 35(3): 263-267.
[5]	李钰莹, 张悦. Sirtuins在乳腺癌中作用机制的研究进展[J]. 实用肿瘤学杂志, 2021, 35(3): 277-281.
[6]	提谦, 张清媛. CDK4/6抑制剂联合内分泌治疗晚期乳腺癌[J]. 实用肿瘤学杂志, 2021, 35(3): 287-290.
[7]	杨敏, 张娇燕, 段丹, 徐兵河. 乳腺癌照顾者研究的文献计量学及可视化分析[J]. 实用肿瘤学杂志, 2021, 35(2): 110-116.
[8]	王健宇, 张显玉, 庞达. Luminal A型乳腺癌新辅助化疗疗效的影响因素分析[J]. 实用肿瘤学杂志, 2021, 35(2): 131-136.
[9]	胡洋, 张清媛. PARP抑制剂治疗BRCA1/2突变转移性乳腺癌的研究进展[J]. 实用肿瘤学杂志, 2021, 35(2): 184-187.
[10]	朱云芳,文洪梅,秦明芳,石青萍,成会荣,高娇,陈杨. 2011—2016年云南省肿瘤登记地区女性乳腺癌发病和死亡情况分析[J]. 实用肿瘤学杂志, 2021, 35(1): 18-22.
[11]	牛明, 于歌. 促进乳腺癌增殖转移和肿瘤干细胞特征的研究[J]. 实用肿瘤学杂志, 2020, 34(6): 518-523.
[12]	刘红, 鲁海玲, 蔡莉. 影像学预测乳腺癌患者预后及新辅助化疗反应的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 535-539.
[13]	肖海帆, 颜仕鹏, 曹世钰, 李娜, 许可葵, 邹艳花, 邓红玉, 杨雯娟, 石朝晖, 廖先珍. 湖南省口腔癌早诊早治项目设计概要[J]. 实用肿瘤学杂志, 2020, 34(6): 544-548.
[14]	袁瑶, 周显礼. 乳腺癌超声特征与腋窝淋巴结转移相关性的研究进展[J]. 实用肿瘤学杂志, 2020, 34(6): 576-580.
[15]	左婷婷, 吴颖, 董首兰, 曲宁, 高岿然, 李梦丹, 刘运泳. 辽宁省沈阳市城市地区2016-2018年度乳腺癌筛查结果分析[J]. 实用肿瘤学杂志, 2020, 34(5): 387-390.

河南省城市地区乳腺癌筛查依从性及其影响因素分析

Analysis of compliance with breast cancer screening and its influencing factors in urban areas of Henan province

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价